The new scope of reusable medical device cleaning validations, resulting from the U.S. Food and Drug Administrations (FDA) proposed changes to 21 CFR 610, is discussed in a new management brief from Microtest Laboratories available for download at http://www.microtestlabs.com/21-cfr-610-paper .
The FDAs proposed amendments to 21 CFR Parts 600, 610, and 680, published in the Federal Register on June 21, 2011, for review and comment, are focused on expanding the scope of the current sections to allow for greater flexibility in testing methodology.
Through these changes, the FDA is embracing the emergence of new non-culture based technologies. If approved, they will provide the opportunity to utilize these methods as alternatives to culture-based sterility tests, explains James E.T. Gebo, BS, MPA, RM (NRCM), technical representative for laboratory services at Microtest Laboratories, in the brief, Summary of Proposed Changes to 21 CFR 610: The New Scope of Cleaning Validations.
The most significant proposed revision is the elimination of the specified sterility test methods, writes Gebo. But while the proposed changes seem extreme at first glance, in the grand scheme they are beneficial for all interested parties.
The brief discusses the potential benefits, including the opportunity for manufacturers and quality control laboratories to streamline their testing and adopt new emerging sterility test technologies such as rapid testing methods employing PCR that will further support the drive to achieve quicker product release.
Download the new free management brief, Summary of Proposed Changes to 21 CFR 610: The New Scope of Cleaning Validations, at http://www.microtestlabs.com/21-cfr-610-paper.
Product Locator: Spring and Early Mother's Day Gift Guide for Infection Prevention Personnel
March 27th 2024Whether it's a spring holiday, birthdays, or no reason at all, infection prevention personnel love to give and receive gifts that help at the end of a stressful day. Infection Control Today® offers some gift ideas for infection prevention personnel and their families.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
Infection Prevention in Low-Resource Settings: Two Infection Preventionists Consult in East Africa
January 29th 2024Infection preventionists Heather Saunders and Stephanie Mayoryk's journey to East Africa emphasizes the positive impact of infection prevention efforts in low-income countries. Despite challenges, their experience encourages IPs to engage globally, fostering hope and passion for providing excellent patient care.